Forecasted pharmaceutical sales in Canada display a steady year-on-year growth. The sales values (in Billion US Dollars) for 2024 through 2028 are as follows:
- 2024: $32.4B
- 2025: $33.24B
- 2026: $34.07B
- 2027: $34.88B
- 2028: $35.68B
The year-on-year variations are:
- 2025: 2.59%
- 2026: 2.50%
- 2027: 2.38%
- 2028: 2.29%
The Compound Annual Growth Rate (CAGR) from 2024 to 2028 is approximately 2.44%.
Aging population, increasing demand for chronic and specialty treatments, and advancements in biotechnology will likely drive continued growth in pharmaceutical sales in Canada. Regulatory changes and price control policies could also impact the market dynamics.
